Airway inflammation and altered alveolar macrophage phenotype pattern after repeated low-dose allergen exposure of atopic asthmatic subjects

Clinical and Experimental Allergy

Volumn 29, Issue 12, 1999, Pages 1632-1640

  Lensmar, C ^a   Prieto, J ^a   Dahlen B ^a   Eklund, A ^a   Grunewald, J ^a   Roquet, A ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Accessory function; Allergic inflammation; Asthma; Low dose allergen provocation; Macrophage phenotype

Indexed keywords

ALLERGEN; CD11 ANTIGEN; CD16 ANTIGEN; CD71 ANTIGEN; HLA ANTIGEN CLASS 1;

ADULT; ALLERGIC ASTHMA; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; DOSE TIME EFFECT RELATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPATHOGENESIS; LUNG ALVEOLUS MACROPHAGE; MALE; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE;

ADULT; ALLERGENS; ANTIBODIES, MONOCLONAL; ASTHMA; BLOOD PROTEINS; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHOALVEOLAR LAVAGE FLUID; EOSINOPHIL GRANULE PROTEINS; EOSINOPHILS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; HYPERSENSITIVITY, IMMEDIATE; INFLAMMATION; MACROPHAGES, ALVEOLAR; MALE; METHACHOLINE CHLORIDE; POACEAE; POLLEN; RIBONUCLEASES; TREES;

EID: 0033390227     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.1999.00757.x     Document Type: Article

References (41)

1. 1 Spiteri MA, Poulter LW. Characterization of immune inducer and suppressor macrophages from the normal human lung. Clin Exp Immunol 1991; 83:157-62.
2. 2 Spiteri MA, Clarke SW, Poulter LW. Isolation of phenotypically and functionally distinct macrophage subpopulations from human bronchoalveolar lavage. Eur Respir J 1992; 5:717-26.
3. 3 Thepen T, Kraal G, Holt PG. The role of alveolar macrophages in regulation of lung inflammation. Ann N Y Acad Sci 1994; 725:200-6.
4. 4 Holt PG. Current concepts in pulmonary immunology: regulation of primary and secondary T-cell responses to inhaled antigens. Eur Respir Rev 1996; 6:128-35.
5. 5 Gant V, Cluzel M, Shakoor Z, Rees PJ, Lee TH, Hamblin AS. Alveolar macrophage accessory function in bronchial asthma. Am Rev Respir Dis 1992; 146:900-4.
6. 6 Spiteri MA, Knight RA, Jeremy JY, Barnes PJ, Chung KF. Alveolar macrophage-induced suppression of peripheral blood mononuclear cell responsiveness is reversed by in vitro allergen exposure in bronchial asthma. Eur Respir J 1994; 7:1431-8.
7. 7 Poulter LW, Burke CM. Macrophages and allergic lung disease. Immunobiol 1996; 195:574-87.
8. 8 Furuie H, Yamasaki H, Suga M, Ando M. Altered accessory cell function of alveolar macrophages: a possible mechanism for induction of Th2 secretory profile in idiopathic pulmonary sarcoidosis. Eur Respir J 1997; 10:789-94.
9. 9 Poulter LW, Janossy G, Power C, Sreenan S, Burke C. Immunological/physiological relationships in asthma: potential regulation by lung macrophages. Review Immunol Today 1994; 6:258-61.
10. 10 Jansen HM. The role of alveolar macrophages and dendritic cells in allergic airway sensitization. Review. Allergy 1996; 51:279-92.
11. + T cells accumulate in the lungs of patients with allergic asthma after allergen bronchoprovocation. Clin Exp Immunol 1998; 112:1-9.
12. 12 Tang C, Rolland JM, Ward C et al. Differential regulation of allergen-specific TH2-but not TH1-type responses by alveolar macrophages in atopic asthma. J Allergy Clin Immunol 1998; 102:368-75.
13. + T cells. Am J Respir Crit Care Med 1998; 157:1120-6.
14. 14 Chanez P, Vignola AM, Lacoste P, Michel FB, Godard P, Bousquet J. Increased expression of adhesion molecules (ICAM-1 and LFA-1) on alveolar macrophages from asthmatic patients. Allergy 1993; 48:576-80.
15. 15 Humbert M, Grant JA, Tabordabarata L et al. High-affinity IgE receptor (Fc∈RI) -bearing cells in bronchial biopsies from atopic and nonatopic asthmatics. Am J Respir Crit Care Med 1996; 153:1931-7.
16. 16 Viksman MY, Liu MC, Bickel CA, Schleimer RP, Bochner BS. Phenotypic analysis of alveolar macrophages and monocytes in allergic airway inflammation. Am J Respir Crit Care Med 1997; 155:858-63.
17. 17 Pujol JL, Cosso B, Davies JP, Clot J, Michel FB, Goddard PL. Interleukin-1 release by alveolar macrophages in asthmatic patients and healthy subjects. Int Arch Allergy Appl Immunol 1990; 91:207-10.
18. 18 Gosset P, Tsieopoulos A, Wallaert B et al. Increased secretion of tumor necrosis factor alpha and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction. J Allergy Clin Immunol 1991; 88:561-71.
19. 19 Borish L, Mascali JJ, Dishuck J, Beam WR, Rosenwasser LJ. Detection of alveolar macrophage-derived IL-1 beta in asthma. inhibition with corticosteroids. J Immunol 1992; 149:3078-82.
20. 20 Catena E, Mazzarella G, Peluso GF, Micheli P, Cammarata A, Marsico SA. Phenotypic features and secretory pattern of alveolar macrophages in atopic asthmatic patients. Monaldi Arch Chest Dis 1993; 48:6-15.
21. 21 John M, Lim S, Seybold J et al. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1α, granulocyte-macrophage colony-stimulating factor, and interferon-gamma release from alveolar macrophages in asthma. Am J Respir Crit Care Med 1998; 157:256-62.
22. 22 Ihre E, Zetterström O. Increase in nonspecific bronchial responsiveness after repeated inhalation of low doses of allergen. Clin Exp Allergy 1993; 23:298-305.
23. 23 Roquet A, Ihre E, van Hage-Hamsten M, Hallden G, Zetterström O. Allergen-induced inflammation in the nose: a comparison of acute and repeated low-dose allergen exposure. Allergy 1996; 51:42-8.
24. 24 Roquet A, Lagging E, Ihre E et al. No signs of activity markers in peripheral blood despite increased bronchial reactivity after repeated low-dose allergen exposure. APMIS 1998; 106:293-9.
25. 25 Sulakvelidze I, Inman MD, Rerecich T, O'Byrne PM. Increases in airway eosinophils and interleukin-5 with minimal bronchoconstriction during repeated low-dose allergen challenge in atopic asthmatics. Eur Respir J 1998; 11:821-7.
26. 26 Dahlén B, Zetterström O, Björck T, Dahlén S-E. The leukotriene-antagonist ICI-204,219 inhibits the early airway reaction to cumulative bronchial challenge with allergen in atopic asthmatics. Eur Respir J 1994; 7:324-31.
27. 27 Eklund A, Blaschke E. Relationship between changed alveolar-capillary permeability and angiotensin converting enzyme activity in serum in sarcoidosis. Thorax 1986; 41:629-34.
28. 28 Prieto J, Eklund A, Patarroyo M. Regulated expression of integrins and other adhesion molecules during differentiation of monocytes into macrophages. Cell Immunol 1994; 154:191-211.
29. 29 Stent G, Irving L, Lewin S, Crowe SM. The kinetics of surface expression of CD11/CD18 integrins and CD54 on monocytes and macrophages. Clin Exp Immunol 1995; 100:366-76.
30. 30 Van Hal PThW, Wijkhuijs JM, Mulfed PGH, Hoogsteden HC. Proliferation of mature and immature subpopulations of bronchoalveolar monocytes/macrophages and peripheral blood monocytes. Cell Prolif 1995; 28:533-43.
31. 31 Krombach F, Gerlach JT, Padovan C et al. Characterization and quantification of alveolar monocyte-like cells in human chronic inflammatory disease. Eur Respir J 1996; 9:984-91.
32. 32 Wahlström J, Berlin M, Sköld CM, Wigzell H, Eklund A, Grunewald J. Phenotypic analysis of lymphocytes and monocytes/macrophages in peripheral blood and bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis. Thorax 1999; 54:0-8.
33. 33 Beasly R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989; 139:806-17.
34. 34 Poston RN, Chanez P, Lacoste JY, Lichtfield T, Lee TH, Bousquet J. Immunohistochemical characterization of the cellular infiltration in asthmatic bronchi. Am Rev Respir Dis 1992; 145:918-21.
35. 35 Ziegler-Heitbrock HW, Ulevitch RJ. CD14: cell surface receptor and differentiation marker. Immunol Today 1993; 14:121-5.
36. 36 Goyert SM, Ferrero E, Rettig WJ, Yenamandra AK, Obata F, Le Beau MM. The CD14 monocyte differentiation antigen maps to a region encoding growth factors and receptors. Science 1988; 239:497-500.
37. 37 Postma DS, Bleecker ER, Amelung PJ et al. Genetic susceptibility to asthma, bronchial hyperresponsiveness coinherited with a major gene for atopy. N Engl J Med 1995; 333:894-900.
38. 38 Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249:1431-3.
39. 39 Dentener MA, Bazil V, von Asmuth EJ, Ceska M, Buurman WA. Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6, and IL-8 release by human monocytes and alveolar macrophages. J Immunol 1993; 150:2885-91.
40. 40 Zhou LJ, Schwarting R, Smith HM, Tedder TF. A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells and activated lymphocytes is a new member of the immunoglobulin family. J Immunol 1992; 149:735-42.
41. 41 Van den Heuvel MM, Vanhee DDC, Postmus PE, Hoefsmit ECM, Beelen RHJ. Functional and phenotypic differences of monocyte-derived dendritic cells from allergic and nonallergic patients. J Allergy Clin Immunol 1998; 101:90-5.